Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia

Livio Pagano, Gina Zini, Maria Teresa Voso, Alfonso Piciocchi, Luana Fianchi, Giovanna Rosaria Mansueto, Marianna Criscuolo, Pasquale Niscola, Luca Maurillo, Pellegrino Musto, Giovanna Mansueto, Maria Antonietta Aloe-Spiriti, Francesco Buccisano, Adriano Venditti, Andrea Tendas, Anna Lina Piccioni, Roberto Latagliata, Nunzio Filardi, Alberto Fragasso, Susanna FenuMassimo Breccia

Research output: Contribution to journal › Article

23 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences